Wait, Why Is Novo Selling Weight Loss Drugs for So Cheap in China?

Quick Summary:

Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction of what it's charging customers in the US.

Almost every third child in China was deemed overweight back in 2022, and signs point toward the trend accelerating in the coming years.

But getting access to a potentially life-saving drug like Wegovy may prove a lot harder, particularly due to insurance reasons.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Victor Tangermann

Category: Technology

Markets: United StatesCanadaChina

Topics: Novo nordisk Neoscope Ozempic Wegovy Developments Semaglutide China Weight loss drugs

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-24 @ 12:30:30 (13 hours ago)

News Timezone: GMT +8:00

News Source URL: futurism.com

Language: English

Article Length: 547 words

Reading Time: 4 minutes read

Sentences: 27 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Futurism

News ID: 23796512

View Article Analysis

About Futurism

Main Topics: Technology

Official Website: futurism.com

Update Frequency: 2 posts per day

Year Established: 1997

Headquarters: United States

News Last Updated: 9 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #68

Publisher Details

Frequently Asked Questions